Pathstone Family Office’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $9.67M | Buy |
22,208
+9,305
| +72% | +$4.05M | 0.07% | 174 |
|
|
2023
Q2 | $5.62M | Sell |
12,903
-1,017
| -7% | -$443K | 0.08% | 150 |
|
|
2023
Q1 | $6.4M | Sell |
13,920
-20,648
| -60% | -$9.49M | 0.1% | 134 |
|
|
2022
Q4 | $15.5M | Buy |
34,568
+7,052
| +26% | +$3.17M | 0.13% | 121 |
|
|
2022
Q3 | $12.5M | Buy |
27,516
+17,634
| +178% | +$8.02M | 0.11% | 119 |
|
|
2022
Q2 | $4.77M | Sell |
9,882
-283,477
| -97% | -$137M | 0.11% | 108 |
|
|
2022
Q1 | $5.49M | Buy |
293,359
+282,508
| +2,604% | +$5.28M | 0.13% | 79 |
|
|
2021
Q4 | $5.03M | Buy |
10,851
+1,447
| +15% | +$671K | 0.13% | 80 |
|
|
2021
Q3 | $3.51M | Buy |
9,404
+2,876
| +44% | +$1.07M | 0.1% | 102 |
|
|
2021
Q2 | $2.49M | Buy |
6,528
+2,374
| +57% | +$907K | 0.07% | 140 |
|
|
2021
Q1 | $1.49M | Buy |
4,154
+4,010
| +2,785% | +$1.44M | 0.05% | 156 |
|
|
2020
Q4 | $47K | Buy |
+144
| New | +$47K | ﹤0.01% | 518 |
|
|
2019
Q4 | – | Sell |
-136
| Closed | -$32K | – | 483 |
|
|
2019
Q3 | $32K | Sell |
136
-2,074
| -94% | -$488K | ﹤0.01% | 328 |
|
|
2019
Q2 | $624K | Buy |
2,210
+619
| +39% | +$175K | 0.07% | 114 |
|
|
2019
Q1 | $457K | Buy |
1,591
+1,125
| +241% | +$323K | 0.06% | 118 |
|
|
2018
Q4 | $122K | Buy |
+466
| New | +$122K | 0.04% | 114 |
|
|
2017
Q3 | – | Sell |
-950
| Closed | -$179K | – | 218 |
|
|
2017
Q2 | $179K | Sell |
950
-235
| -20% | -$44.3K | 0.08% | 106 |
|
|
2017
Q1 | $196K | Buy |
+1,185
| New | +$196K | 0.11% | 96 |
|